Our proprietary formulation may provide accelerated healing of surface wounds on eyes, skin, and mucosal membranes. These products are uniquely powered by factors and proteins extracted from human plasma, for healing, and chitosan, which is antimicrobial and enables the serum to remain on the surface longer.

The powerful combination of these two components enables a new therapy to potentially provide relief and long-lasting therapeutic action.

Patients who experience conditions such as dry eye disease, wounds or burns on skin and mucous membranes, or chronic moisture may benefit from this fusion of plasma and chitosan as a forward-thinking and potent strategy to potentially address these conditions.

Our initial product will focus on dry eye disease (DED). There are 22 million dry eye patients in the United States and of those only 8 million are treated with 25% reporting satisfaction with their treatment. There is a need for more effective treatments with fewer side effects.

future applications:

We are evaluating disease and region specific applications. In the case of mouth dryness, a gel or spray containing both plasma derivatives and chitosan could provide relief from the discomfort of dryness, promote the healing of mucosal lesions, and may offer sustained hydration. For vaginal dryness, gels or suppositories that incorporate both these components may effectively be impactful.

The combination ensures may do more than provide relief and protection.  It may also create an environment conducive to tissue repair and regeneration.